Results

Prosus NV

08/16/2022 | Press release | Distributed by Public on 08/16/2022 09:05

Update on repurchase programme

Prosus N.V.
(Incorporated in the Netherlands)
(Legal Entity Identifier: 635400Z5LQ5F9OLVT688)
AEX and JSE Share Code: PRX ISIN: NL0013654783
(Prosus)

Update on repurchase programme

Prosus today announces an update to the open-ended, repurchase programme in respect of the ordinary shares N in the capital of Prosus ("Prosus Shares") and N ordinary shares in the share capital of Naspers ("Naspers Shares"), from the respective Prosus and Naspers (together the "Group") free-float shareholders (together the "Repurchase Programme") announced on 27 June 2022.

As part of the Repurchase Programme, for the period between 8 August 2022 and 12 August 2022, Prosus repurchased 2,431,395 Prosus Shares at an average price of €63.2249 per share for a total consideration of €153,724,717 (US$157,716,610).

Considering the regulatory requirement to provide weekly updates on Prosus Shares repurchased, the company decided to also provide voluntary updates on the Naspers Shares repurchased.

For the period between 8 August 2022 and 12 August 2022, the Group purchased 329,534 Naspers Shares at an average price of ZAR2,452.5897 per share for a total consideration of ZAR808,211,701 (US$49,490,541).

More information on the Repurchase Programme is available on www.prosus.com/news/investors-shareholder-information/.

Amsterdam, the Netherlands, 16 August 2022

JSE sponsor to Prosus:
Investec Bank Limited

Disclaimer

The Repurchase Programme is being conducted in accordance with Articles 5(1) and 5(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse ("Market Abuse Regulation") and Articles 2 to 4 of Commission Delegated Regulation (EU) 2016/1052 supplementing the Market Abuse Regulation with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures (the "Delegated Regulation"). This document is issued in connection with the disclosure and reporting obligation set out in Article 2(1) of the Delegated Regulation.

This document contains information that qualifies as inside information within the meaning of Article 7(1) of the Market Abuse Regulation.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

The information contained in this announcement may contain forward-looking statements, estimates and projections. Forward-looking statements involve all matters that are not historical and may be identified by the words "anticipate", "believe", "estimate", "expect", "intend", "may", "should", "will", "would" and similar expressions or their negatives, but the absence of these words does not necessarily mean that a statement is not forward-looking. These statements reflect Prosus's intentions, beliefs or current expectations, involve elements of subjective judgement and analysis and are based upon the best judgement of Prosus as of the date of this announcement, but could prove to be wrong. These statements are subject to change without notice and are based on a number of assumptions and entail known and unknown risks and uncertainties. Therefore, you should not rely on these forward-looking statements as a prediction of actual results.

Any forward-looking statements are made only as of the date of this announcement and neither Prosus nor any other person gives any undertaking, or is under any obligation, to update these forward-looking statements for events or circumstances that occur subsequent to the date of this announcement or to update or keep current any of the information contained herein, any changes in assumptions or changes in factors affecting these statements and this announcement is not a representation by Prosus or any other person that they will do so, except to the extent required by law.